Fig. 4From: The prognostic value of a combined immune score in tumor and immune cells assessed by immunohistochemistry in triple-negative breast cancerKaplan–Meier analysis of progression-free survival (PFS) and overall survival (OS), according to the tumor cells combined immune score (TCIS) and immune cells combined immune score (ICIS) groups. A PFS in TCIS, BPFS in ICIS, C OS in TCIS, and D OS in ICISBack to article page